Correction: HBV genotypes and drug resistance mutations in antiretroviral treatment-naive and treatment-experienced HBV-HIV-coinfected patients (Antiviral Therapy (2016) DOI: 10.3851/IMP3055)

Timothy N.A. Archampong, Ceejay L. Boyce, Margaret Lartey, Kwamena W. Sagoe, Adjoa Obo-Akwa, Ernest Kenu, Jason T. Blackard, Awewura Kwara

Research output: Contribution to journalComment/debate

Abstract

The publisher would like to report an error that appeared in a recently published article [1]. In the abstract the sentence 'Of these 63 patients, 27 (42.9%) were ART37 experienced, and 58 (92.1%) had HBV genotype E.' should appear as 'Of these 63 patients, 27 (42.9%) were ART-experienced and 58 (92.1%) had HBV genotype E'. The publisher apologizes for this error.

Original languageEnglish
Pages (from-to)91
Number of pages1
JournalAntiviral Therapy
Volume22
Issue number1
DOIs
Publication statusPublished - 2017

Fingerprint

Dive into the research topics of 'Correction: HBV genotypes and drug resistance mutations in antiretroviral treatment-naive and treatment-experienced HBV-HIV-coinfected patients (Antiviral Therapy (2016) DOI: 10.3851/IMP3055)'. Together they form a unique fingerprint.

Cite this